Showing results (121-130 of 321) with videos related to
Sort By:
Pageof 33
Experimental Hematology|August 6, 2002
In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissueChiara Dell'Agnola, Cristina Rabascio, Patrizia Mancuso, et al.Nature Communications|September 4, 2019
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapySung Pil Hong, Thalia E Chan, Ylenia Lombardo, et al.Clinical Breast Cancer|December 12, 2013
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expressionAlessandra Balduzzi, Vincenzo Bagnardi, Nicole Rotmensz, et al.Cancer Research|June 19, 2004
Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cellsCristina Rabascio, Elisabetta Muratori, Patrizia Mancuso, et al.International Journal of Cancer|July 7, 2016
Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCISAliana Guerrieri-Gonzaga, Ivana Sestak, Matteo Lazzeroni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvementMarco Colleoni, Nicole Rotmensz, Giulia Peruzzotti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter studyDaniele Laszlo, Giovanna Andreola, Luigi Rigacci, et al.Pharmacoeconomics - Open|March 4, 2021
Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?Giancarlo Pruneri, Filippo De Braud, Anna Sapino, et al.JAMA Oncology|June 8, 2023
Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A ReviewRobert Haddad, Rossella Elisei, Ana O Hoff, et al.Cancer Biomarkers : Section a of Disease Markers|August 7, 2023
Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practiceAndrea Vingiani, Daniele Lorenzini, Elena Conca, et al.Pageof 33